CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) had its price target hoisted by equities researchers at Truist Financial from $100.00 to $120.00 in a report issued on Wednesday,Benzinga reports.

Patrick Industries (NASDAQ:PATK – Get Free Report) had its target price raised by investment analysts at Truist Financial ...

Truist Financial Corporation ( NYSE: TFC) UBS Financial Services Conference February 11, 2025 1:00 PM ET Buddy, as I say, no rest for the weary. But obviously my energy levels are back up, because we ...

Truist Financial analyst Terry Tillman reiterated a Buy rating on Manhattan Associates (MANH – Research Report) today. The company’s shares ...

A former UBS registered investment advisor has left the firm to start her own RIA in partnership with support platform ...

Each advisor has been vetted by SmartAsset ... such as Truist CD early withdrawal penalties. Like many financial institutions, Truist can change its CD rates daily or even weekly in response ...

The Truist Securities price target objective ... that’s why it could be a good idea to speak to a fiduciary financial advisor about your goals today. Start by taking this retirement quiz right ...

Patrick Breen is a financial advisor in Ewing, NJ. He has been in practice for 12 years, the last 7 months at Truist Investment Services, Inc.. Patrick Breen is a financial advisor in Ewing ...

Sharin Akhtar is a financial advisor in Charleston, WV. They have been in practice for 26 years, the last 4 years at Truist Advisory Services Inc. Sharin Akhtar is a financial advisor in ...

The Financial Services Observer: The U.S. Department of Labor’s Fiduciary Rule for Advisors Could Reshape the Financial Sector. In 2011, he ranked second in the Investment Services industry in ...